Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q1 EPS of $0.23, $0.57 worse than the analyst estimate of $0.80. Revenue for the quarter came in at $509 million versus the consensus estimate of $515 million.

For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.